Axe Compute reports FY2025 net loss of $232.9M; no compute revenue; holds $40M in ATH tokens

Axe Compute Inc.

Total revenue $125,284, entirely from legacy Drug Discovery; no compute revenue in 2025.
Net loss from continuing ops $232.9M, including $152.5M unrealized loss on digital assets (ATH) and $52.7M derivative loss.
Cash and equivalents $10.8M vs $0.6M; stockholders' equity improved to $47.7M from deficit of $0.2M.
Held 6.348B ATH tokens aggregate ($40M FMV after discount); $343.5M raised via PIPE in Oct 2025.
CEO Christopher Miglino appointed Feb 2026; board reconstituted; GPU network access over 435,000 GPUs established.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Axe Compute Inc. reported the fiscal year ended December 31, 2025 results: revenue $125,284, net income $232.9 million.

Period: the fiscal year ended December 31, 2025
Revenue: $125,284
Net income: $232.9 million
Result: reported results

Exact text from the filing

center facilities or GPU hardware; the Company’s platform provides marketplace access to this network on an asset-light model. FULL YEAR 2025 FINANCIAL HIGHLIGHTS Total Revenue: $125,284, derived entirely from the Company’s Drug Discovery Services legacy segment. No compute revenue was recognized in fiscal 2025, as the Axe Compute segment launched in September 2025

View on SEC.gov

1349 earnings releases filed in the last 30 days. Browse all earnings releases →

Axe Compute Inc. filing history →

Source: SEC EDGAR

accession 0001171843-26-002096

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.